Department of Pathology Research Division Success Stories
Azeddine Atfi is a coauthor on this publication:
A new publication from the Clevenger Lab; current Department of Pathology coauthors include Justin Craig, Jennifer Koblinski, Charles Clevenger
Jennifer Koblinski is a coauthor on this publication:
- Mohammad Al-Zubi completed his PhD in the VCU Integrative Life Sciences Program
- Chuck Harrell is a co-author on this publication, other co-authors that are members of the Pathology Department include Scott Turner and Andrea Ferreira-Gonzalez: https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-020-01300-y
- Chuck Harrell has been asked to serve on an upcoming NIGMS study section for the Support of Competitive Research (SCORE) Program* (SC1, SC2, SC3)
- Youngman Oh and Qing Cai are co-authors on these recent publications:
- Senthil Radhakrishnan has been awarded a one-year NIH/NIA Alzheimer’s Supplement of $116,667 (Direct Cost) to his R01 to investigate the Nrf1 pathway in neuronal cells.
- Azeddine Atfi (left) is a coauthor on this publication: https://www.sciencedirect.com/science/article/pii/S0002944020303710?via%3Dihub
- Jackie Grible earned a PhD from the Department of Human and Molecular Genetics
- Parash Parajuli, Thien Ly Nguyen, and Azeddine Atfi published this paper: https://www.life-science-alliance.org/content/3/6/e201900573
- Azeddine Atfi had his R01 grant funded by the NCI: "Targeting Transglutaminase 2 in cancer cachexia".
- Azeddine Atfi has been named as a member of the Tumor Progression and Metastasis Study Section for the NIH.
- Azeddine Atfi has been named a Director of the Massey Cancer Center Cancer Biology Program.
- Chuck Harrell had his R01 grant funded by the NCI: "Circumventing acquired carboplatin resistance in triple-negative breast cancers". Mikhail Dozmorov and Jason Reed are Co-Investigators.
- Chuck Harrell has been appointed to the Massey Cancer Center Protocol Review and Monitoring Committee for Clinical Trials.
- Janakiram R. Vangala, Ajay Potluri and Senthil K. Radhakrishnan published this paper: https://www.mdpi.com/2218-273X/10/4/501
- Amy Northrop (pictured at microscope) is awarded the Roscoe D. Hughes fellowship from the Human Medical Genetics Department and she received the Charles C. Clayton Scholarship from VCU School of Medicine.
- Senthil Radhakrishnan has been as to serve on an upcoming Drug Discovery and Molecular Pharmacology study section.
- Paula Bos (left) is highlighted in this article: https://massey.vcu.edu/about/news-center/2020-archive/massey-scientists-join-international-effort-to-streamline-brain-metastasis-research/
- Tia Turner was selected for the VCU Graduate School Distinguished Dissertation Award for Life Sciences: https://rampages.us/vcucctr/2020/07/14/wright-center-graduate-wins-vcus-distinguished-dissertation-award/
- Chuck Harrell and Sahib Sohal are coauthors on this publication:https://meridian.allenpress.com/radiation-research/article/194/2/103/439618/The-Roles-of-Autophagy-and-Senescence-in-the-Tumor
- Amy Northrop earned a PhD from the Department of Human and Molecular Genetics
• Jackie Grible and Alicia Woock both received 1) Early Career Forum Travel Awards and 2) Graduate School Travel Grants to attend the annual Endocrine Society Meeting in San Francisco.
• A recent publication from the Harrell Lab: The utility of the “Glowing Head” mouse for breast cancer metastasis research. https://link.springer.com/article/10.1007/s10585-020-10020-8
Department of Pathology contributors include; Mohammad Al-Zubi, David Boyd, Chuck Harrell.
• A recent publication from the Harrell Lab: Identification of synergistic drug combinations using breast cancer patient-derived xenografts. https://www.nature.com/articles/s41598-020-58438-0
Department of Pathology contributors include; Tia Turner, Mohammad Al-Zubi, Chuck Harrell.
• Dr. Koblinski is a co-author on this paper: Anillin regulates breast cancer cell migration, growth, and metastasis by non-canonical mechanisms involving control of cell stemness and differentiation. https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-019-1241-x
• A recent publication from the Radhakrishnan Lab: Disabling the Protease DDI2 Attenuates the Transcriptional Activity of NRF1 and Potentiates Proteasome Inhibitor Cytotoxicity. https://www.mdpi.com/1422-0067/21/1/327
Department of Pathology contributors include; Amy Northrop, Janakiram Vangala, Senthil Radhakrishnan.
• Dr. Radhakrishnan has been named to the Editorial Board of PLOS ONE.
• Dr. Radhakrishnan has been invited to serve as Ad Hoc reviewer for the “Transition to Independence” NIH study section.